The volume of private credit facilities refinanced in the broadly syndicated loan market in Europe so far in 2024 — or that are in the process of being refinanced — has already reached an eye-catching total of roughly €4.2 billion, according to LCD.
For CLOs, these deals offer a strong source of new-money supply in the absence of M&A activity, but cash-rich direct lenders are responding head-on to the challenge and repricing margins lower on key takeout targets.
Germany-based payroll and HR software group P&I Personal & Informatik last week became the latest European borrower to approach the market with a loan-for-private credit takeout, when it set a Tuesday lender call for a €455 million five-year deal. The borrower is an existing syndicated name, but the loan will — as well as funding a dividend — refinance a unitranche facility placed in December 2022.
In this way, P&I's transaction is similar to deals from Group.one and Planet, which have both refinanced unitranche loans that were added into their syndicated stacks. In these instances, the borrowers opted to refinance all loans into one large liquid financing — which in the case of Group.one resulted in an overall reduction in headline spreads. (There are also some private credit transactions being refinanced by bonds — for example, Ardonagh is refinancing part of its unitranche with a high-yield bond alongside existing private credit investors).
Cost of living
Costs are the primary reason why borrowers are returning to the syndicated market. “The cost comparison between liquid and private credit markets over the past two years has been on a fully flexed underwritten basis for new-money LBOs,” explained a banker. “These deals today are all best-efforts refinancings, so there is no flex and they offer a saving that is too big for sponsors' capital markets teams to ignore.”
Looking closer at pricing, the average spread for a euro-denominated B rated TLB was 421 bps for the first quarter to March 11, according to LCD, and April Insurance for example took out a unitranche priced at roughly E+600 with a €1.2 billion facility that also supported an acquisition, and allocated at E+400 and par on March 6. Final terms here came tight of talk of E+400-425 and 99.5, and the deal has held up in secondary in a 100/100.50 context. April was a previous syndicated name, and it was a deal ripe for a refinancing. “People have always liked that name,” confirmed a manager.

Sponsors are also looking to normalize hybrid capital structures placed in reaction to the dislocated markets of the past two years. Spanish fertility clinic operator Ivirma, for example, is on track to close a €1 billion-equivalent term loan to refinance an €820 million term loan initially targeted for syndication, but was eventually placed with a group of direct lenders with a margin of E+575, according to sources.
Supply driver
The scale of the opportunity means sources agree direct-lending takeouts could be the major driver of supply for European syndicated markets running into the second half of the year. “These deals are going to make up the bulk of activity for some banks,” confirmed one manager. In loans, for example, a deal is tipped to emerge soon to refinance unitranche facilities from Goldman Sachs AM-backed Swedish IT firm Advania.
Bonds will also benefit from this dynamic, and NB Renaissance-backed Neopharmed is said to be planning a €750 million bond to refinance a unitranche in the next month. Italian food group IRCA is also understood to be looking to high yield, in this case to refinance a €650 million unitranche.
How much all this activity will amount to in terms of new-money syndicated supply is a matter for discussion, but one banker was willing to estimate that roughly €10 billion of paper from direct lenders could return to the floating-rate syndicated markets over the next couple of months, including a handful of deals sized at more than €1 billion. The potential here may be even larger, and according to research penned by Barclays' Craig Nicol (published Feb. 29), €50 billion of supply has been gobbled up by private credit from across syndicated loans and bonds in Europe since 2019.

But private credit providers are not sitting back and letting their gains slip back into the lap of the syndicated market. “Private credit has raised a lot of money over the past few years and they have to deploy, which means they have to be competitive on price,” said a banker. As a result, lenders are moving to cut margins preemptively on key deals.
This activity includes Unither Pharmaceuticals, which is seeking to cut margins by 50-75 bps on roughly €440 million of debt, and Trescal, where lenders have sliced 100 bps of an E+600-650 margin from more than €500 million of loans. Of the two deals, Trescal was seen as a particular target for a loan takeout, given the calibration group was a former — and like April, a popular — syndicated name. The firm moved to private credit at the end of 2022 as part of its EQT-led buyout.
Product offering
But syndicated markets are also seeking to step up their offering in areas other than pricing, and by providing products such as delayed-draw term loans.
Delayed-draw facilities have always been a feature of syndicated loans, but they are unpopular with cashflow lenders such as CLOs, given they bring a commitment with a ticking-fee schedule until drawn. In hot markets, sponsors also look to stretch the interest-free period as the loans are attractive to those names looking at buy-and-build strategies, as they save interest-rate costs while they work on potential deals. Meanwhile, the structure of private credit funds means these lenders have been happy to provide DDTLs, and such facilities have therefore become a key part of their competitive offering.
“Direct lenders have been throwing these things around like confetti, so we have to look at them more seriously,” said one manager. A banker agreed, adding that without their inclusion, deals would continue to be lost to direct lenders. “Funds hate them, but they have to ask would they rather not have the deal at all?”
Among recent deals, Eleda included a €153 million delayed-draw alongside the €765 million term loan B that backed the firm’s Bain-led buyout. The deal closed at E+450 with a 0% floor offered at 99, which is in the middle of the fairway for pricing on new-money single-B deals.

However, some funds note a more nuanced picture. “There are deals that are going to be more appropriate for direct lenders than syndicated markets,” said one manager, adding that even if early stage buy-and-build buyouts went to direct lenders, they would still be refinanced in the syndicated market due to the flexibility of the loan product that allows par repayment at will.
“The market is short of paper and there is intense competition for mandates so banks are competing fiercely, and that includes through features like delayed-draws,” said one banker. What’s more, in a heavily banked market such as Europe, arrangers are also competing in other ways — including through their ability to offer chunky undrawns.
An increasing number of larger direct lenders are able to provide an undrawn line as part of their underwriting offer, but these facilities often lack the flexibility of a typical bank-provided product. This means they more closely resemble, sources explain, a capex line in that once it is drawn it cannot be repaid. Banks are then needed to take out the facility post-close to provide the type of backup facility most borrowers require. “Direct lenders do them as they are comfortable with the credit, and so are willing to take the extra turn of leverage on the term debt if they are not replaced,” said one source.
Revolving door
Revolvers, however, are not attractive pieces of paper in general, and may struggle to find lender interest unless there are relationship draws in the provision of other banking services. “A revolver is often the most difficult part of the capital stack to place,” said one banker. A lawyer agreed, noting that commercial banks are increasingly less willing to provide revolvers for other debt providers’ deals. That said, a banker added that revolvers are also to some extent commoditized in that they typically form one turn of leverage of the capital stack, meaning larger facilities are not necessarily attractive for sponsors. “European banks can compete through a larger revolver but these are only going to be useful for those borrowers in certain sectors and with specific needs,” said the banker at a universal shop, who noted that even undrawn facilities still come with commitment fees.
Either way, for syndicated lenders, all this activity promises supply for a market that has been plagued by a shortage of paper over the past two years and scant M&A activity. Meanwhile, LCD’s rolling three-month supply figure — calculated as CLO issuance minus new issues tracked in the Morningstar European Leveraged Loan Index (ELLI), minus repayments — has flagged a shortage since February 2022 (apart from a small surplus of €70 million in December 2022).

Signs of summer
M&A supply continues to be slow for all lenders. That said, after promising an uptick for the past two years, bankers say they are now seeing tangible signs of improvement, which should lead to more supply from the second half onwards. There has been a smattering of sponsor-to-sponsor transactions, and in March Cinven agreed to take majority control of Alter Domus in a €4.9 billion deal that is expected to be backed by a syndicated financing.
Private credit is not going to stop competing for deals, and in its Feb. 29 report, Barclays argued this remains a good thing for public markets. “The symbiotic relationship of public and private credit has strengthened in recent years, and we expect that to continue as competition in the lending landscape increases, both in the US and Europe,” the report said.
FangXiaNuo/Getty Images
Learn about our editorial standards.